Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Holcombe Grier"'
Autor:
Jason Glover, Tsz-Kwong Man, Donald A Barkauskas, David Hall, Tanya Tello, Mary Beth Sullivan, Richard Gorlick, Katherine Janeway, Holcombe Grier, Ching Lau, Jeffrey A Toretsky, Scott C Borinstein, Chand Khanna, Timothy M Fan, COG Osteosarcoma Biology Group
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181204 (2017)
The prospective banking of osteosarcoma tissue samples to promote research endeavors has been realized through the establishment of a nationally centralized biospecimen repository, the Children's Oncology Group (COG) biospecimen bank located at the B
Externí odkaz:
https://doaj.org/article/ab541fd17df649658863b9bd49e7bec6
Publikováno v:
Cancer. 91:613-621
BACKGROUND Therapy with alkylating agents, such as cyclophosphamide, can be associated with irreversible gonadal toxicity in male survivors of adult cancer. To the authors's knowledge the effect of high dose therapy with cyclophosphamide during child
Autor:
V. Michael Whitehead, Mark L. Bernstein, Beverly Bell, Holcombe Grier, George R. Buchanan, Susan Devine, Charles Pratt, Jeffrey P. Krischer, Zoanne Dreyer, Vita Land, Faith Kung
Publikováno v:
Cancer. 72:1790-1794
Background. Ifosfamide has previously been shown to be active as a single agent and in combination with doxorubicin, etoposide, and teniposide in pediatric solid tumors and adult acute leukemia. The authors performed a dose-escalation trial of ifosfa
Autor:
Rui, Yang, Rebecca, Sowers, BethAnne, Mazza, John H, Healey, Andrew, Huvos, Holcombe, Grier, Mark, Bernstein, G Peter, Beardsley, Mark D, Krailo, Meenakshi, Devidas, Joseph R, Bertino, Paul A, Meyers, Richard, Gorlick
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(2)
High-dose methotrexate is a standard component of therapy for high-grade osteosarcoma. Its effectiveness may be limited by intrinsic and acquired resistance. Decreased reduced folate carrier (RFC) expression has been shown in approximately half of os
Publikováno v:
Journal of Clinical Oncology. 23:6438-6439
Autor:
Harrison Ball, Richard D. Gelber, Paul N. Anderson, A. T. Van Oosterom, Sandra Schafer, Janet Woodcock, Patricia A. Ganz, Michael Friedman, Rodger J. Winn, John Benear, Leslie C. Ford, Robert Justice, Collier Smyth, John Burrows, James L. Wade, Jane C. Weeks, John Fetting, Susan K. Parsons, Susan Braun, Patricia Legant, Peter C Raich, Gerald Hanks, Katy Benjamin, Holcombe Grier, Harmar Brereton, Mark Levine, Thomas J. Smith, Charles L. Bennett, Alfred M. Cohen, Charles D. Cobau
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(2)
In 1993, the Health Services Research Committee of the American Society of Clinical Oncology (ASCO) charged an Outcomes Working Group with defining the outcomes of adult and pediatric cancer treatment to be used for technology assessment and developm
Autor:
Holcombe Grier
Publikováno v:
Current Opinion in Oncology. 6:365-366